Trial Profile

Methylene Blue as a Third-line Vasopressor in Septic Shock to Maintain Hemodynamics

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 01 Aug 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Methylthioninium chloride-Provepharm (Primary) ; Hydrocortisone; Norepinephrine; Phenylephrine; Vasopressin
Indications Septic shock
Focus Therapeutic Use

Most Recent Events

22 Jul 2022 Planned End Date changed from 1 Mar 2022 to 1 Nov 2024.
22 Jul 2022 Planned primary completion date changed from 1 Oct 2021 to 1 Oct 2024.
02 Jan 2020 Status changed from not yet recruiting to recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com